NCT04901650

Brief Summary

Pain is a sensation of discomfort, annoyance or distress, described as an unpleasant subjective sensory and emotional experience associated with actual or potential injury, and may associate vegetative, psychological, emotional, and behavioral responses. It is the main reason for medical consultation and in many cases it is assumed as inevitable. It is also a clinical symptom and generates negative consequences. As a result, people who suffer from "pain" may see their quality of life diminished. On many occasions, either due to the high healthcare burden, because pain is not the reason for consultation or because the main pathology suffered by the patient is not the cause of the pain, not attention is given to it. The objective of this study is to evaluate the prevalence of pain in the inpatient population, analyzing its presence and intensity in patients admitted to the Doctor Negrín University Hospital of Gran Canaria. Likewise, it is interesting to know what percentage of patients with pain have analgesics and the degree of relief with the treatment received. As a secondary objective, it is intended to establish whether there is a relationship between factors dependent on the patient and the presence of pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
274

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 17, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 25, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

May 25, 2021

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 26, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2021

Completed
Last Updated

October 5, 2021

Status Verified

October 1, 2021

Enrollment Period

1 day

First QC Date

May 17, 2021

Last Update Submit

October 4, 2021

Conditions

Keywords

Pain prevalencePain managementOpioidsNon-steroidal antiinflamatory drugs

Outcome Measures

Primary Outcomes (1)

  • Pain Prevalence

    Pain prevalence will be obtained from patients who have been hospitalized for more than 24 hours at the Hospital.

    24 hours throughout the hospital admission

Secondary Outcomes (2)

  • Patient satisfaction assessed by VAS (from 0 to 10)

    24 hours throughout the hospital admission

  • Percentage of patients receiving drugs for pain management

    24 hours throughout the hospital admission

Study Arms (1)

Inpatient population

A survey will be administered to find out the prevalence of pain in hospitalized patients for any cause and its intensity. The medical history will be reviewed to assess the presence of pain medications and their impact on the pain perception and patients' satisfaction.

Diagnostic Test: Survey

Interventions

SurveyDIAGNOSTIC_TEST

A survey will be administered to find out the prevalence of pain in hospitalized patients for any cause and its intensity. The medical history will be reviewed to assess the presence of pain medications and their impact on the pain perception and patients' satisfaction.

Inpatient population

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients hospitalized for more than 24 hours will be surveyed at the same date.

You may qualify if:

  • hospital admission for more than 24 hours
  • age \>18 years old
  • desire and express authorization of the individual to participate in the study by accepting informed consent

You may not qualify if:

  • refusal of the subject to participate in the study
  • alterations in cognitive status, speech or comprehension problems
  • language barrier
  • psychiatric pathology
  • Covid patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ángel Becerra

Las Palmas de Gran Canaria, Las Palmas, 35019, Spain

Location

MeSH Terms

Conditions

PainAgnosia

Interventions

Fertility

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

Reproductive Physiological PhenomenaReproductive and Urinary Physiological Phenomena

Study Officials

  • Aurelio Rodríguez-Pérez, PhD

    Hospital Universitario de Gran Canaria Doctor Negrín

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 17, 2021

First Posted

May 25, 2021

Study Start

May 25, 2021

Primary Completion

May 26, 2021

Study Completion

September 15, 2021

Last Updated

October 5, 2021

Record last verified: 2021-10

Locations